EUVIMEDEUVIMED entdecken
Open Access

Targeting HCG18 counteracts ferroptosis resistance via blocking the miR-30a-5p/RRM2/GSS pathway in hepatocellular carcinoma

Tian Zhan, Yawei Liu, Shuoke Duan, Chen Lu, Heng Jia, Ming Jin, Jie Li, Xinru Du, Sizheng Sun, Yuan Li, Jianping Zhang

International Journal of Biological Sciences · 21.03.2025 · 21 (6) · 2550-2567

DOI: 10.7150/ijbs.104127 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, erschienen am 21.03.2025. Verfasst von Tian Zhan und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Ferroptosis, MicroRNAs, Liver Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularFerroptosisMicroRNAsLiver NeoplasmsRibonucleoside Diphosphate ReductaseRNA, Long NoncodingHumansAnimalsMiceMice, NudeCell Line, TumorGene Expression Regulation, NeoplasticMaleFemaleMice, Inbred BALB CDrug Resistance, NeoplasmCell Proliferation

Stichwörter der Autor:innen

GSSHCG18RRM2ferroptosis therapyhepatocellular carcinoma

Substanzen

MicroRNAsRibonucleoside Diphosphate ReductaseRNA, Long Noncodingribonucleotide reductase M2MIRN30a microRNA, humanMIRN30b microRNA, human

Autor:innen und Institutionen

  • Department of General Surgery, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, 210009, China.
  • Department of General Surgery, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China.
  • Department of Gastroenterology, the Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou, 215031, China.
  • The Key Laboratory of Modern Toxicology, Ministry of Education, School of Public Health, Nanjing Medical University, Nanjing, 211166, China.
  • Department of General Surgery, Sir Run Run Hospital of Nanjing Medical University, Nanjing, 211100, China.
  • Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, 210000, China.

Zitieren

APA

Zhan, T., Liu, Y., Duan, S., Lu, C., Jia, H., Jin, M., Li, J., Du, X., Sun, S., Li, Y., & Zhang, J. (2025). Targeting HCG18 counteracts ferroptosis resistance via blocking the miR-30a-5p/RRM2/GSS pathway in hepatocellular carcinoma. International Journal of Biological Sciences, 21(6), 2550-2567. https://doi.org/10.7150/ijbs.104127

Vancouver

Zhan T, Liu Y, Duan S, Lu C, Jia H, Jin M, et al. Targeting HCG18 counteracts ferroptosis resistance via blocking the miR-30a-5p/RRM2/GSS pathway in hepatocellular carcinoma. International Journal of Biological Sciences. 2025;21(6):2550-2567. doi:10.7150/ijbs.104127

BibTeX
@article{Zhan2025,
  author = {Zhan, Tian and Liu, Yawei and Duan, Shuoke and Lu, Chen and Jia, Heng and Jin, Ming and Li, Jie and Du, Xinru and Sun, Sizheng and Li, Yuan and Zhang, Jianping},
  title = {Targeting HCG18 counteracts ferroptosis resistance via blocking the miR-30a-5p/RRM2/GSS pathway in hepatocellular carcinoma},
  journal = {International Journal of Biological Sciences},
  year = {2025},
  volume = {21},
  number = {6},
  pages = {2550--2567},
  doi = {10.7150/ijbs.104127}
}
Kostenlos starten →